SK bioscience: Valuation, Funding & Investors
SK bioscience is a South Korea–based biotechnology company focused on the development, manufacturing and commercialization of vaccines and biologics for infectious diseases. The company maintains end-to-end capabilities spanning research and clinical development, GMP vaccine production, and global supply partnerships to support public health immunization programs and commercial markets.
Leadership & Board
- Current Number of Employees
- 456
- Current LinkedIn Followers
- 62,855
Latest Estimated Valuation
- Total Amount Raised
- $40M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $40M
- Latest Funding Round
- Investment
Employee Trend
SK bioscience had 456 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
SK bioscience had 62,855 followers as of November 9, 2026. The number of followers increased by 1,384 (2.25%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 25, 2022 | Investment | $40.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Coalition for Epidemic Preparedness Innovations | Investment |
Similar Companies
A snapshot of private companies similar to SK bioscience, helping you discover and navigate related company profiles.
Related News and Analysis









